Should O O O O
Traditional O O O O
Vaccines O O O O
Be O O O O
Used O O O O
in O O O O
the O O O O
Global O O O O
Fight O O O O
Against O O O O
Covid? O O O O
Researcher O O O O
Maria O O O O
Elena O O O O
Bottazzi O O O O
says O O O O
such O O O O
vaccines O O O O
may O O O O
be O O O O
key O O O O
to O O O O
protecting O O O O
individuals O O O O
in O O O O
middle- O O O O
and O O O O
low-income O O O O
countries O O O O
One Reason 2 O O
reason Reason 2 O O
for Reason 2 O O
this Reason 2 O O
imbalance Reason 2 O O
is Reason 2 O O
that Reason 2 O O
the Reason 2 O O
mRNA Reason 2 O O
vaccines Reason 2 O O
that Reason 2 O O
have Reason 2 O O
been Reason 2 O O
so Reason 2 O O
successful Reason 2 O O
in Reason 2 O O
wealthy Reason 2 O O
nations Reason 2 O O
are Reason 2 O O
novel, Reason 2 O O
expensive Reason 2 O O
and Reason 2 O O
technologically Reason 2 O O
challenging Reason 2 O O
to Reason 2 O O
produce. Reason 2 O O
Only Reason 2 O O
a Reason 2 O O
few Reason 2 O O
companies Reason 2 O O
have Reason 2 O O
the Reason 2 O O
expertise Reason 2 O O
to Reason 2 O O
manufacture Reason 2 O O
them Reason 2 O O
and Reason 2 O O
high-income Reason 2 O O
countries Reason 2 O O
have Reason 2 O O
hoarded Reason 2 O O
more Reason 2 O O
than Reason 2 O O
70 Reason 2 O O
percent Reason 2 O O
of Reason 2 O O
doses. Reason 2 O O
Efforts Reason 2 O O
to Reason 2 O O
ramp Reason 2 O O
up Reason 2 O O
production Reason 2 O O
of Reason 2 O O
mRNA Reason 2 O O
vaccines Reason 2 O O
in Reason 2 O O
middle- Reason 2 O O
and Reason 2 O O
low-income Reason 2 O O
countries Reason 2 O O
are Reason 2 O O
now Reason 2 O O
underway, Reason 2 O O
including Reason 2 O O
in Reason 2 O O
some Reason 2 O O
African Reason 2 O O
countries. Reason 2 O O
But Reason 2 O O
mRNA Reason 2 O O
is Reason 2 O O
fragile Reason 2 O O
and Reason 2 O O
tricky Reason 2 O O
to Reason 2 O O
handle, Reason 2 O O
requiring Reason 2 O O
some Reason 2 O O
vaccines Reason 2 O O
to Reason 2 O O
be Reason 2 O O
stored Reason 2 O O
at Reason 2 O O
ultra-cold Reason 2 O O
temperatures. Reason 2 O O
This Reason 2 O O
adds Reason 2 O O
to Reason 2 O O
the Reason 2 O O
complexity Reason 2 O O
of Reason 2 O O
vaccine Reason 2 O O
manufacture Reason 2 O O
and Reason 2 O O
to Reason 2 O O
the Reason 2 O O
challenges Reason 2 O O
in Reason 2 O O
distribution Reason 2 O O
in Reason 2 O O
remote Reason 2 O O
areas. Reason 2 O O
Vaccines O O O O
that O O O O
use O O O O
genetically O O O O
modified O O O O
viruses O O O O
to O O O O
introduce O O O O
coronavirus O O O O
proteins, O O O O
like O O O O
the O O O O
Johnson O O O O
& O O O O
Johnson O O O O
vaccine, O O O O
are O O O O
also O O O O
relatively O O O O
new O O O O
and O O O O
technically O O O O
challenging O O O O
to O O O O
produce. O O O O
A Reason 5 O O
better Reason 5 O O
option Reason 5 O O
is Reason 5 O O
to Reason 5 O O
turn Reason 5 O O
to Reason 5 O O
more Reason 5 O O
traditional Reason 5 O O
vaccine Reason 5 O O
technologies Reason 5 O O
that Reason 5 O O
don't Reason 5 O O
require Reason 5 O O
as Reason 5 O O
much Reason 5 O O
new Reason 5 O O
infrastructure, Reason 5 O O
says Reason 5 O O
[Maria Reason 5 O O
Elena Reason 5 O O
Bottazzi](https://www.bcm.edu/people-search/maria-bottazzi-18431), Reason 5 O O
a Reason 5 O O
vaccine Reason 5 O O
researcher Reason 5 O O
at Reason 5 O O
Baylor Reason 5 O O
College Reason 5 O O
of Reason 5 O O
Medicine Reason 5 O O
in Reason 5 O O
Houston. Reason 5 O O
Bottazzi Reason 5 O O
coauthored Reason 5 O O
a Reason 5 O O
look Reason 5 O O
at Reason 5 O O
[Covid-19 Reason 5 O O
vaccines Reason 5 O O
that Reason 5 O O
use Reason 5 O O
more Reason 5 O O
accessible Reason 5 O O
technologies Reason 5 O O
](https://www.annualreviews.org/doi/10.1146/annurev-med-042420-113212)in Reason 5 O O
the Reason 5 O O
2022 Reason 5 O O
Annual Reason 5 O O
Review Reason 5 O O
of Reason 5 O O
Medicine. Reason 5 O O
Such Reason 5 O O
vaccines Reason 5 O O
deliver Reason 5 O O
whole, Reason 5 O O
inactivated Reason 5 O O
viruses Reason 5 O O
or Reason 5 O O
fragments Reason 5 O O
of Reason 5 O O
viral Reason 5 O O
protein Reason 5 O O
to Reason 5 O O
stimulate Reason 5 O O
the Reason 5 O O
immune Reason 5 O O
system Reason 5 O O
to Reason 5 O O
produce Reason 5 O O
antibodies, Reason 5 O O
and Reason 5 O O
they Reason 5 O O
can Reason 5 O O
be Reason 5 O O
more Reason 5 O O
than Reason 5 O O
90 Reason 5 O O
percent Reason 5 O O
effective Reason 5 O O
at Reason 5 O O
preventing Reason 5 O O
disease, Reason 5 O O
just Reason 5 O O
like Reason 5 O O
the Reason 5 O O
mRNA Reason 5 O O
vaccines. Reason 5 O O
Unlike Reason 5 O O
mRNA Reason 5 O O
technology, Reason 5 O O
factories Reason 5 O O
already Reason 5 O O
exist Reason 5 O O
in Reason 5 O O
many Reason 5 O O
middle- Reason 5 O O
and Reason 5 O O
low-income Reason 5 O O
countries Reason 5 O O
to Reason 5 O O
produce Reason 5 O O
these Reason 5 O O
older Reason 5 O O
types Reason 5 O O
of Reason 5 O O
vaccines, Reason 5 O O
which Reason 5 O O
include Reason 5 O O
the Reason 5 O O
familiar Reason 5 O O
hepatitis Reason 5 O O
A Reason 5 O O
and Reason 5 O O
B Reason 5 O O
and Reason 5 O O
polio Reason 5 O O
vaccines. Reason 5 O O
Such Reason 5 O O
shots Reason 5 O O
also Reason 5 O O
tend Reason 5 O O
to Reason 5 O O
cost Reason 5 O O
less Reason 5 O O
than Reason 5 O O
the Reason 5 O O
new Reason 5 O O
mRNA Reason 5 O O
vaccines: Reason 5 O O
a Reason 5 O O
few Reason 5 O O
dollars Reason 5 O O
a Reason 5 O O
dose, Reason 5 O O
compared Reason 5 O O
to Reason 5 O O
more Reason 5 O O
than Reason 5 O O
$10 Reason 5 O O
per Reason 5 O O
dose. Reason 5 O O
In O O O O
partnership O O O O
with O O O O
the O O O O
Indian O O O O
company O O O O
Biological O O O O
E, O O O O
Bottazzi O O O O
and O O O O
her O O O O
Baylor O O O O
colleague O O O O
and O O O O
coauthor O O O O
Peter O O O O
Hotez O O O O
have O O O O
developed O O O O
one O O O O
such O O O O
Covid-19 O O O O
vaccine, O O O O
Corbevax, O O O O
using O O O O
protein O O O O
fragments, O O O O
which O O O O
is O O O O
now O O O O
licensed O O O O
for O O O O
use O O O O
in O O O O
India O O O O
and O O O O
Botswana. O O O O
Knowable O O O O
Magazine O O O O
spoke O O O O
with O O O O
Bottazzi O O O O
about O O O O
what O O O O
makes O O O O
a O O O O
vaccine O O O O
suitable O O O O
for O O O O
global O O O O
use O O O O
and O O O O
some O O O O
of O O O O
the O O O O
barriers O O O O
that O O O O
have O O O O
prevented O O O O
more O O O O
widespread O O O O
vaccination. O O O O
This O O O O
conversation O O O O
has O O O O
been O O O O
edited O O O O
for O O O O
length O O O O
and O O O O
clarity. O O O O
What O O O O
constitutes O O O O
a O O O O
"good" O O O O
vaccine O O O O
for O O O O
global O O O O
use? O O O O
You O O O O
have O O O O
to O O O O
have O O O O
a O O O O
solid O O O O
technology O O O O
that O O O O
is O O O O
appropriate O O O O
for O O O O
the O O O O
region, O O O O
including O O O O
scalability, O O O O
storage O O O O
conditions, O O O O
the O O O O
characteristics O O O O
of O O O O
the O O O O
product O O O O
itself. O O O O
You O O O O
have O O O O
to O O O O
have O O O O
the O O O O
right O O O O
infrastructure O O O O
to O O O O
make, O O O O
deliver O O O O
and O O O O
regulate O O O O
vaccines. O O O O
And O O O O
you O O O O
have O O O O
to O O O O
have O O O O
all O O O O
the O O O O
supplies O O O O
that O O O O
are O O O O
needed O O O O
to O O O O
make O O O O
them. O O O O
We O O O O
can't O O O O
have O O O O
sole O O O O
sources, O O O O
because O O O O
then O O O O
countries O O O O
block O O O O
export, O O O O
as O O O O
we O O O O
saw O O O O
with O O O O
US-made O O O O
reagents O O O O
or O O O O
India-made O O O O
vaccines. O O O O
Why O O O O
haven't O O O O
mRNA O O O O
vaccines O O O O
like O O O O
those O O O O
made O O O O
by O O O O
Pfizer O O O O
and O O O O
Moderna O O O O
been O O O O
the O O O O
solution O O O O
globally? O O O O
We Reason 1 O O
could Reason 1 O O
not Reason 1 O O
make Reason 1 O O
them Reason 1 O O
at Reason 1 O O
large-enough Reason 1 O O
scale. Reason 1 O O
There Reason 1 O O
were Reason 1 O O
not Reason 1 O O
enough Reason 1 O O
production Reason 1 O O
facilities Reason 1 O O
to Reason 1 O O
do Reason 1 O O
this Reason 1 O O
— Reason 1 O O
it Reason 1 O O
was Reason 1 O O
impossible. Reason 1 O O
So Reason 1 O O
even Reason 1 O O
though Reason 1 O O
they Reason 1 O O
did Reason 1 O O
an Reason 1 O O
amazing Reason 1 O O
job Reason 1 O O
scaling Reason 1 O O
to Reason 1 O O
the Reason 1 O O
amount Reason 1 O O
they Reason 1 O O
did, Reason 1 O O
it Reason 1 O O
wasn't Reason 1 O O
enough. Reason 1 O O
We Reason 1 O O
could Reason 1 O O
not Reason 1 O O
distribute Reason 1 O O
them Reason 1 O O
equally. Reason 1 O O
And Reason 1 O O
of Reason 1 O O
course, Reason 1 O O
then Reason 1 O O
some Reason 1 O O
countries Reason 1 O O
benefited Reason 1 O O
more Reason 1 O O
than Reason 1 O O
others, Reason 1 O O
because Reason 1 O O
there's Reason 1 O O
the Reason 1 O O
power Reason 1 O O
of Reason 1 O O
purchase. Reason 1 O O
If Reason 1 O O
you Reason 1 O O
can Reason 1 O O
buy Reason 1 O O
them, Reason 1 O O
you Reason 1 O O
hoard Reason 1 O O
the Reason 1 O O
supply. Reason 1 O O
Is O O O O
there O O O O
a O O O O
better O O O O
option? O O O O
Protein-based Reason 5 O O
vaccines Reason 5 O O
are Reason 5 O O
well Reason 5 O O
suited Reason 5 O O
for Reason 5 O O
becoming Reason 5 O O
a Reason 5 O O
global Reason 5 O O
health Reason 5 O O
vaccine. Reason 5 O O
You Reason 5 O O
have Reason 5 O O
a Reason 5 O O
diversified Reason 5 O O
group Reason 5 O O
of Reason 5 O O
manufacturers Reason 5 O O
that Reason 5 O O
already Reason 5 O O
have Reason 5 O O
all Reason 5 O O
the Reason 5 O O
know-how Reason 5 O O
as Reason 5 O O
well Reason 5 O O
as Reason 5 O O
the Reason 5 O O
prior Reason 5 O O
track Reason 5 O O
record Reason 5 O O
of Reason 5 O O
making Reason 5 O O
them, Reason 5 O O
so Reason 5 O O
they Reason 5 O O
don't Reason 5 O O
have Reason 5 O O
to Reason 5 O O
start Reason 5 O O
from Reason 5 O O
scratch. Reason 5 O O
And Reason 5 O O
they're Reason 5 O O
easier Reason 5 O O
to Reason 5 O O
make Reason 5 O O
at Reason 5 O O
large Reason 5 O O
scale, Reason 5 O O
so Reason 5 O O
you Reason 5 O O
have Reason 5 O O
economies Reason 5 O O
of Reason 5 O O
scale. Reason 5 O O
But O O O O
I O O O O
think O O O O
the O O O O
most O O O O
important O O O O
feature O O O O
is O O O O
social. O O O O
It O O O O
really O O O O
depends O O O O
on O O O O
the O O O O
acceptance O O O O
of O O O O
these O O O O
products. O O O O
[A O O O O
vaccine O O O O
has O O O O
to O O O O
bring O O O O
confidence O O O O
to O O O O
the O O O O
user](https://knowablemagazine.org/article/health-disease/2021/how-to-convince-people-to-accept-covid19-vaccine). O O O O
People O O O O
are O O O O
afraid O O O O
— O O O O
not O O O O
only O O O O
because O O O O
they're O O O O
in O O O O
the O O O O
middle O O O O
of O O O O
a O O O O
pandemic, O O O O
but O O O O
they're O O O O
also O O O O
afraid O O O O
of O O O O
all O O O O
these O O O O
tools O O O O
that O O O O
are O O O O
new. O O O O
Some O O O O
people O O O O
are O O O O
clearly O O O O
early O O O O
adopters, O O O O
but O O O O
there O O O O
are O O O O
also O O O O
many O O O O
of O O O O
us O O O O
who O O O O
prefer O O O O
to O O O O
wait O O O O
a O O O O
little O O O O
bit O O O O
and O O O O
see O O O O
what O O O O
happens O O O O
before O O O O
putting O O O O
ourselves O O O O
at O O O O
risk. O O O O
At O O O O
some O O O O
level, O O O O
people O O O O
are O O O O
always O O O O
more O O O O
confident O O O O
when O O O O
they O O O O
know O O O O
it's O O O O
a O O O O
vaccine O O O O
that's O O O O
similar O O O O
to O O O O
one O O O O
they've O O O O
been O O O O
using O O O O
for O O O O
many O O O O
years. O O O O
That's O O O O
why O O O O
a O O O O
vaccine O O O O
such O O O O
as O O O O
the O O O O
one O O O O
we O O O O
developed O O O O
can O O O O
help. O O O O
People Reason 4 O O
are Reason 4 O O
more Reason 4 O O
familiar Reason 4 O O
with Reason 4 O O
it Reason 4 O O
because Reason 4 O O
protein-based Reason 4 O O
vaccines Reason 4 O O
are Reason 4 O O
a Reason 4 O O
technology Reason 4 O O
they've Reason 4 O O
used Reason 4 O O
before. Reason 4 O O
We Reason 4 O O
get Reason 4 O O
many Reason 4 O O
emails Reason 4 O O
from Reason 4 O O
people Reason 4 O O
asking, Reason 4 O O
"When Reason 4 O O
is Reason 4 O O
your Reason 4 O O
Corbevax Reason 4 O O
vaccine Reason 4 O O
coming Reason 4 O O
to Reason 4 O O
the Reason 4 O O
US? Reason 4 O O
This Reason 4 O O
is Reason 4 O O
the Reason 4 O O
vaccine Reason 4 O O
I've Reason 4 O O
been Reason 4 O O
waiting Reason 4 O O
for Reason 4 O O
because Reason 4 O O
I've Reason 4 O O
used Reason 4 O O
this Reason 4 O O
kind Reason 4 O O
of Reason 4 O O
vaccine Reason 4 O O
before." Reason 4 O O
And Reason 4 O O
this Reason 4 O O
is Reason 4 O O
not Reason 4 O O
only Reason 4 O O
happening Reason 4 O O
here, Reason 4 O O
but Reason 4 O O
it's Reason 4 O O
happening Reason 4 O O
all Reason 4 O O
over Reason 4 O O
the Reason 4 O O
world. Reason 4 O O
And O O O O
how O O O O
you O O O O
establish O O O O
clinical O O O O
safety O O O O
and O O O O
efficacy O O O O
is O O O O
important. O O O O
We O O O O
want O O O O
to O O O O
see O O O O
more O O O O
inclusion O O O O
of O O O O
diverse O O O O
populations. O O O O
I O O O O
think O O O O
we O O O O
have O O O O
that O O O O
issue O O O O
now O O O O
with O O O O
Covid: O O O O
Many O O O O
studies O O O O
that O O O O
evaluate O O O O
the O O O O
vaccines O O O O
aren't O O O O
done O O O O
in O O O O
the O O O O
populations O O O O
where O O O O
these O O O O
vaccines O O O O
are O O O O
eventually O O O O
going O O O O
to O O O O
be O O O O
used. O O O O
We O O O O
need O O O O
more O O O O
studies O O O O
in O O O O
those O O O O
countries O O O O
like O O O O
Honduras, O O O O
Ethiopia O O O O
and O O O O
Thailand. O O O O
Even O O O O
for O O O O
familiar O O O O
vaccine O O O O
technologies, O O O O
it O O O O
takes O O O O
a O O O O
lot O O O O
of O O O O
work O O O O
to O O O O
develop O O O O
a O O O O
vaccine O O O O
for O O O O
a O O O O
new O O O O
disease. O O O O
You've O O O O
argued O O O O
that O O O O
this O O O O
should O O O O
be O O O O
done O O O O
all O O O O
around O O O O
the O O O O
world, O O O O
locally O O O O
or O O O O
regionally, O O O O
rather O O O O
than O O O O
relying O O O O
on O O O O
a O O O O
few O O O O
nations. O O O O
Doesn't O O O O
that O O O O
lead O O O O
to O O O O
redundant O O O O
effort? O O O O
You O O O O
would O O O O
think O O O O
that O O O O
it's O O O O
redundant, O O O O
but O O O O
Covid O O O O
clearly O O O O
showed O O O O
us O O O O
that O O O O
manufacturers O O O O
and O O O O
supply O O O O
chains O O O O
are O O O O
too O O O O
consolidated O O O O
in O O O O
very O O O O
few O O O O
regions. O O O O
When O O O O
you O O O O
have O O O O
to O O O O
address O O O O
a O O O O
situation O O O O
urgently, O O O O
having O O O O
those O O O O
manufacturers O O O O
concentrated O O O O
in O O O O
very O O O O
few, O O O O
mostly O O O O
high-income O O O O
areas O O O O
blocks O O O O
access, O O O O
and O O O O
rich O O O O
countries O O O O
can O O O O
hike O O O O
up O O O O
the O O O O
prices O O O O
or O O O O
nationalize O O O O
the O O O O
vaccines. O O O O
We O O O O
are O O O O
not O O O O
saying O O O O
you O O O O
have O O O O
to O O O O
reinvent O O O O
the O O O O
wheel O O O O
everywhere O O O O
— O O O O
but O O O O
strategically, O O O O
regions O O O O
have O O O O
to O O O O
be O O O O
able O O O O
to O O O O
be O O O O
self-sufficient O O O O
so O O O O
that O O O O
there O O O O
can O O O O
be O O O O
more O O O O
equity. O O O O
How Reason 4 O O
does Reason 4 O O
your Reason 4 O O
vaccine Reason 4 O O
— Reason 4 O O
which Reason 4 O O
is Reason 4 O O
being Reason 4 O O
developed Reason 4 O O
by Reason 4 O O
an Reason 4 O O
Indian Reason 4 O O
company, Reason 4 O O
Biological Reason 4 O O
E Reason 4 O O
— Reason 4 O O
help Reason 4 O O
achieve Reason 4 O O
this? Reason 4 O O
We Reason 4 O O
gave Reason 4 O O
BioE Reason 4 O O
the Reason 4 O O
recipe, Reason 4 O O
but Reason 4 O O
ultimately Reason 4 O O
they Reason 4 O O
needed Reason 4 O O
to Reason 4 O O
develop Reason 4 O O
the Reason 4 O O
vaccine Reason 4 O O
themselves. Reason 4 O O
They Reason 4 O O
had Reason 4 O O
to Reason 4 O O
figure Reason 4 O O
out Reason 4 O O
how Reason 4 O O
to Reason 4 O O
make Reason 4 O O
it Reason 4 O O
industrially. Reason 4 O O
They Reason 4 O O
had Reason 4 O O
to Reason 4 O O
become Reason 4 O O
innovators, Reason 4 O O
and Reason 4 O O
now Reason 4 O O
they Reason 4 O O
can Reason 4 O O
teach Reason 4 O O
others Reason 4 O O
to Reason 4 O O
do Reason 4 O O
it, Reason 4 O O
so Reason 4 O O
they Reason 4 O O
can Reason 4 O O
all Reason 4 O O
make Reason 4 O O
their Reason 4 O O
own. Reason 4 O O
That's Reason 4 O O
very Reason 4 O O
different, Reason 4 O O
because Reason 4 O O
it's Reason 4 O O
not Reason 4 O O
coming Reason 4 O O
from Reason 4 O O
the Reason 4 O O
traditional Reason 4 O O
multinational Reason 4 O O
model Reason 4 O O
of, Reason 4 O O
"I'm Reason 4 O O
handing Reason 4 O O
it Reason 4 O O
over Reason 4 O O
and Reason 4 O O
you Reason 4 O O
have Reason 4 O O
to Reason 4 O O
do Reason 4 O O
it Reason 4 O O
the Reason 4 O O
way Reason 4 O O
I Reason 4 O O
tell Reason 4 O O
you Reason 4 O O
to." Reason 4 O O
You're Reason 4 O O
incentivizing Reason 4 O O
and Reason 4 O O
enabling Reason 4 O O
indigenous Reason 4 O O
production Reason 4 O O
and Reason 4 O O
creativity. Reason 4 O O
How O O O O
would O O O O
you O O O O
respond O O O O
to O O O O
concerns O O O O
that O O O O
some O O O O
countries O O O O
may O O O O
lack O O O O
the O O O O
technical O O O O
expertise O O O O
to O O O O
produce O O O O
high-quality O O O O
vaccines, O O O O
or O O O O
the O O O O
regulatory O O O O
rigor O O O O
to O O O O
evaluate O O O O
them? O O O O
I Reason 5 O O
would Reason 5 O O
totally Reason 5 O O
disagree Reason 5 O O
that Reason 5 O O
these Reason 5 O O
manufacturers, Reason 5 O O
especially Reason 5 O O
middle-income-country Reason 5 O O
manufacturers, Reason 5 O O
are Reason 5 O O
in Reason 5 O O
a Reason 5 O O
lesser Reason 5 O O
category Reason 5 O O
compared Reason 5 O O
to Reason 5 O O
a Reason 5 O O
multinational Reason 5 O O
company. Reason 5 O O
They Reason 5 O O
already Reason 5 O O
produce Reason 5 O O
many Reason 5 O O
vaccines. Reason 5 O O
They Reason 5 O O
have Reason 5 O O
already Reason 5 O O
gone Reason 5 O O
through Reason 5 O O
clinical Reason 5 O O
evaluations Reason 5 O O
by Reason 5 O O
many Reason 5 O O
regulatory Reason 5 O O
agencies. Reason 5 O O
There Reason 5 O O
are Reason 5 O O
quality Reason 5 O O
regulatory Reason 5 O O
agencies Reason 5 O O
in Reason 5 O O
places Reason 5 O O
like Reason 5 O O
Indonesia Reason 5 O O
and Reason 5 O O
India Reason 5 O O
that Reason 5 O O
have Reason 5 O O
been Reason 5 O O
working Reason 5 O O
for Reason 5 O O
years, Reason 5 O O
aligned Reason 5 O O
with Reason 5 O O
international Reason 5 O O
standards. Reason 5 O O
They've Reason 5 O O
proven Reason 5 O O
themselves Reason 5 O O
already. Reason 5 O O
BioE Reason 5 O O
is Reason 5 O O
working Reason 5 O O
for Reason 5 O O
authorization Reason 5 O O
from Reason 5 O O
the Reason 5 O O
World Reason 5 O O
Health Reason 5 O O
Organization. Reason 5 O O
They're Reason 5 O O
working Reason 5 O O
with Reason 5 O O
the Reason 5 O O
Australian Reason 5 O O
regulatory Reason 5 O O
agency Reason 5 O O
because Reason 5 O O
that's Reason 5 O O
one Reason 5 O O
of Reason 5 O O
the Reason 5 O O
stringent Reason 5 O O
regulatory Reason 5 O O
agencies Reason 5 O O
that Reason 5 O O
can Reason 5 O O
provide Reason 5 O O
an Reason 5 O O
add-on Reason 5 O O
quality Reason 5 O O
stamp Reason 5 O O
on Reason 5 O O
top Reason 5 O O
of Reason 5 O O
what Reason 5 O O
Indian Reason 5 O O
regulators Reason 5 O O
can Reason 5 O O
give. Reason 5 O O
I Reason 5 O O
think Reason 5 O O
it's Reason 5 O O
false Reason 5 O O
to Reason 5 O O
say Reason 5 O O
that Reason 5 O O
just Reason 5 O O
because Reason 5 O O
the Reason 5 O O
vaccines Reason 5 O O
are Reason 5 O O
produced Reason 5 O O
in Reason 5 O O
India, Reason 5 O O
they Reason 5 O O
have Reason 5 O O
a Reason 5 O O
different Reason 5 O O
standard Reason 5 O O
than Reason 5 O O
if Reason 5 O O
they Reason 5 O O
were Reason 5 O O
produced Reason 5 O O
in Reason 5 O O
the Reason 5 O O
US Reason 5 O O
or Reason 5 O O
Europe. Reason 5 O O
Why O O O O
are O O O O
Covid O O O O
vaccines O O O O
that O O O O
use O O O O
the O O O O
older, O O O O
more O O O O
familiar O O O O
technologies O O O O
only O O O O
now O O O O
becoming O O O O
available? O O O O
What O O O O
made O O O O
them O O O O
so O O O O
much O O O O
slower O O O O
to O O O O
develop? O O O O
It's Reason 2 O O
not Reason 2 O O
slowness. Reason 2 O O
We Reason 2 O O
had Reason 2 O O
a Reason 2 O O
[protein-based Reason 2 O O
vaccine] Reason 2 O O
technology Reason 2 O O
ready Reason 2 O O
three Reason 2 O O
months Reason 2 O O
into Reason 2 O O
the Reason 2 O O
pandemic. Reason 2 O O
And Reason 2 O O
we Reason 2 O O
handed Reason 2 O O
it Reason 2 O O
over Reason 2 O O
to Reason 2 O O
Biological Reason 2 O O
E Reason 2 O O
in Reason 2 O O
May Reason 2 O O
2020. Reason 2 O O
BioE Reason 2 O O
struggled Reason 2 O O
to Reason 2 O O
develop Reason 2 O O
it. Reason 2 O O
They Reason 2 O O
did Reason 2 O O
it Reason 2 O O
as Reason 2 O O
fast Reason 2 O O
as Reason 2 O O
they Reason 2 O O
could Reason 2 O O
— Reason 2 O O
it's Reason 2 O O
just Reason 2 O O
that Reason 2 O O
they Reason 2 O O
certainly Reason 2 O O
did Reason 2 O O
not Reason 2 O O
receive Reason 2 O O
the Reason 2 O O
financial Reason 2 O O
support Reason 2 O O
and Reason 2 O O
they Reason 2 O O
did Reason 2 O O
not Reason 2 O O
receive Reason 2 O O
the Reason 2 O O
governmental Reason 2 O O
support, Reason 2 O O
the Reason 2 O O
political Reason 2 O O
will. Reason 2 O O
Governments Reason 2 O O
said Reason 2 O O
we Reason 2 O O
don't Reason 2 O O
need Reason 2 O O
you Reason 2 O O
— Reason 2 O O
we're Reason 2 O O
going Reason 2 O O
to Reason 2 O O
deal Reason 2 O O
with Reason 2 O O
our Reason 2 O O
new Reason 2 O O
technologies, Reason 2 O O
so Reason 2 O O
we're Reason 2 O O
not Reason 2 O O
going Reason 2 O O
to Reason 2 O O
give Reason 2 O O
you Reason 2 O O
the Reason 2 O O
funding. Reason 2 O O
Now Reason 2 O O
they're Reason 2 O O
realizing Reason 2 O O
they Reason 2 O O
made Reason 2 O O
a Reason 2 O O
mistake. Reason 2 O O
Now Reason 2 O O
they Reason 2 O O
say, Reason 2 O O
"We Reason 2 O O
want Reason 2 O O
you." Reason 2 O O
You've O O O O
made O O O O
your O O O O
vaccine O O O O
technology O O O O
available O O O O
to O O O O
all, O O O O
patent-free. O O O O
Should O O O O
all O O O O
manufacturers O O O O
do O O O O
that? O O O O
There O O O O
are O O O O
some O O O O
technologies, O O O O
like O O O O
the O O O O
RNA O O O O
technologies, O O O O
which O O O O
are O O O O
newer, O O O O
where O O O O
there's O O O O
a O O O O
logic O O O O
why O O O O
they O O O O
might O O O O
want O O O O
to O O O O
protect O O O O
it, O O O O
because O O O O
arguably O O O O
they O O O O
were O O O O
developing O O O O
it O O O O
for O O O O
many O O O O
other O O O O
therapeutics. O O O O
They O O O O
may O O O O
be O O O O
more O O O O
cautious O O O O
in O O O O
saying O O O O
let's O O O O
open O O O O
it O O O O
up. O O O O
We O O O O
could O O O O
have O O O O
patent-protected, O O O O
but O O O O
we O O O O
decided O O O O
not O O O O
to. O O O O
We O O O O
didn't O O O O
want O O O O
barriers. O O O O
We O O O O
basically O O O O
said, O O O O
"Look, O O O O
you O O O O
want O O O O
to O O O O
try O O O O
our O O O O
strategy, O O O O
you O O O O
can O O O O
do O O O O
it O O O O
by O O O O
yourself, O O O O
because O O O O
it's O O O O
all O O O O
published. O O O O
But O O O O
if O O O O
you O O O O
want O O O O
help, O O O O
we'd O O O O
be O O O O
very O O O O
interested O O O O
to O O O O
do O O O O
co-development O O O O
with O O O O
you." O O O O
Covid-19 O O O O
won't O O O O
be O O O O
the O O O O
last O O O O
pandemic. O O O O
Are O O O O
there O O O O
lessons O O O O
we O O O O
need O O O O
to O O O O
learn O O O O
for O O O O
next O O O O
time? O O O O
I Reason 5 O O
think Reason 5 O O
we Reason 5 O O
need Reason 5 O O
to Reason 5 O O
empower Reason 5 O O
countries, Reason 5 O O
especially Reason 5 O O
in Reason 5 O O
the Reason 5 O O
low-middle-income Reason 5 O O
regions Reason 5 O O
— Reason 5 O O
not Reason 5 O O
only Reason 5 O O
with Reason 5 O O
the Reason 5 O O
technology Reason 5 O O
itself, Reason 5 O O
but Reason 5 O O
with Reason 5 O O
regulation, Reason 5 O O
how Reason 5 O O
they Reason 5 O O
create Reason 5 O O
the Reason 5 O O
public Reason 5 O O
health Reason 5 O O
systems. Reason 5 O O
We Reason 5 O O
need Reason 5 O O
to Reason 5 O O
empower Reason 5 O O
them Reason 5 O O
to Reason 5 O O
be Reason 5 O O
more Reason 5 O O
self-sufficient, Reason 5 O O
where Reason 5 O O
they Reason 5 O O
can Reason 5 O O
build Reason 5 O O
a Reason 5 O O
solid Reason 5 O O
workforce Reason 5 O O
and Reason 5 O O
avoid Reason 5 O O
brain Reason 5 O O
drain, Reason 5 O O
but Reason 5 O O
then Reason 5 O O
give Reason 5 O O
them Reason 5 O O
the Reason 5 O O
accountability Reason 5 O O
that Reason 5 O O
they Reason 5 O O
can Reason 5 O O
create Reason 5 O O
their Reason 5 O O
own Reason 5 O O
infrastructure Reason 5 O O
for Reason 5 O O
building Reason 5 O O
that Reason 5 O O
regionally Reason 5 O O
or Reason 5 O O
locally. Reason 5 O O
Not Reason 5 O O
every Reason 5 O O
country Reason 5 O O
has Reason 5 O O
to Reason 5 O O
be Reason 5 O O
self-sufficient Reason 5 O O
for Reason 5 O O
absolutely Reason 5 O O
everything, Reason 5 O O
but Reason 5 O O
they Reason 5 O O
should Reason 5 O O
be Reason 5 O O
complementary Reason 5 O O
to Reason 5 O O
each Reason 5 O O
other. Reason 5 O O
Our Reason 5 O O
vision Reason 5 O O
is Reason 5 O O
of Reason 5 O O
all Reason 5 O O
working Reason 5 O O
together, Reason 5 O O
in Reason 5 O O
the Reason 5 O O
good Reason 5 O O
times Reason 5 O O
and Reason 5 O O
the Reason 5 O O
bad Reason 5 O O
times. Reason 5 O O
But Reason 5 O O
that Reason 5 O O
has Reason 5 O O
to Reason 5 O O
come Reason 5 O O
with Reason 5 O O
political Reason 5 O O
will. Reason 5 O O
Why O O O O
should O O O O
people O O O O
in O O O O
wealthier O O O O
countries O O O O
care O O O O
about O O O O
global O O O O
vaccine O O O O
equity? O O O O
There's O O O O
obviously O O O O
a O O O O
humanitarian O O O O
argument O O O O
— O O O O
but O O O O
is O O O O
there O O O O
also O O O O
a O O O O
practical O O O O
reason O O O O
to O O O O
invest O O O O
dollars O O O O
or O O O O
doses O O O O
to O O O O
vaccinate O O O O
people O O O O
elsewhere? O O O O
We Reason 5 O O
are Reason 5 O O
a Reason 5 O O
big Reason 5 O O
community. Reason 5 O O
Even Reason 5 O O
diseases Reason 5 O O
that Reason 5 O O
primarily Reason 5 O O
affect Reason 5 O O
somewhere Reason 5 O O
else Reason 5 O O
are Reason 5 O O
eventually Reason 5 O O
going Reason 5 O O
to Reason 5 O O
impact Reason 5 O O
us. Reason 5 O O
We Reason 5 O O
see Reason 5 O O
that Reason 5 O O
in Reason 5 O O
Covid. Reason 5 O O
It's Reason 5 O O
clear Reason 5 O O
that Reason 5 O O
the Reason 5 O O
variants Reason 5 O O
arose Reason 5 O O
from Reason 5 O O
the Reason 5 O O
lack Reason 5 O O
of Reason 5 O O
us Reason 5 O O
ensuring Reason 5 O O
other Reason 5 O O
regions Reason 5 O O
have Reason 5 O O
equitable Reason 5 O O
access Reason 5 O O
to Reason 5 O O
very Reason 5 O O
important Reason 5 O O
tools Reason 5 O O
like Reason 5 O O
vaccines, Reason 5 O O
drugs Reason 5 O O
and Reason 5 O O
diagnostics. Reason 5 O O
Helping Reason 5 O O
others Reason 5 O O
is Reason 5 O O
really Reason 5 O O
helping Reason 5 O O
ourselves. Reason 5 O O
